title: Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency.
abstract: Approximately 10% of the patients diagnosed with type 2 diabetes (T2D) have detectable serum levels of glutamic acid decarboxylase 65 autoantibodies (GADA). These patients usually progress to insulin dependency within a few years, and are classified as being latent autoimmune diabetes in adults (LADA). A decrease in the frequency of peripheral blood natural killer (NK) cells has been reported recently in recent-onset T1D and in high-risk individuals prior to the clinical onset. As NK cells in LADA patients have been investigated scarcely, the aim of this study was to use multicolour flow cytometry to define possible deficiencies or abnormalities in the frequency or activation state of NK cells in LADA patients prior to insulin dependency. All patients were GADA-positive and metabolically compensated, but none were insulin-dependent at the time blood samples were taken. LADA patients exhibited a significant decrease in NK cell frequency in peripheral blood compared to healthy individuals (P=0.0018), as reported previously for recent-onset T1D patients. Interestingly, NKG2D expression was increased significantly (P<0.0001), whereas killer cell immunoglobulin-like receptor (KIR)3DL1 expression was decreased (P<0.0001) within the NK cell population. These observations highlight a defect in both frequency and activation status of NK cells in LADA patients and suggest that this immunological alteration may contribute to the development of autoimmune diabetes by affecting peripheral tolerance. Indeed, recent evidence has demonstrated a regulatory function for NK cells in autoimmunity. Moreover, the decrease in NK cell number concords with observations obtained in recent-onset T1D, implying that similar immunological dysfunctions may contribute to the progression of both LADA and T1D.
authors.affiliation: Cellular Autoimmunity Unit, Department of Clinical Sciences, Malmö University Hospital, Malmö, Sweden.
authors.forename: C
authors.initials: C
authors.lastname: Akesson
authors.forename: K
authors.initials: K
authors.lastname: Uvebrant
authors.forename: C
authors.initials: C
authors.lastname: Oderup
authors.forename: K
authors.initials: K
authors.lastname: Lynch
authors.forename: R A
authors.initials: RA
authors.lastname: Harris
authors.forename: A
authors.initials: A
authors.lastname: Lernmark
authors.forename: C-D
authors.initials: CD
authors.lastname: Agardh
authors.forename: C M
authors.initials: CM
authors.lastname: Cilio
mesh_terms: D000328:Adult; D017668:Age of Onset; D000368:Aged; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000175:diagnosis / Q000276:immunology*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis; D003937:Diagnosis, Differential; D018450:Disease Progression; D005260:Female; D005968:Glutamate Decarboxylase / Q000276:immunology; D006683:HLA-DQ Antigens / Q000032:analysis; D059866:HLA-DQ beta-Chains; D006801:Humans; D007108:Immune Tolerance; D016130:Immunophenotyping; D007328:Insulin / Q000097:blood / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology*; D018655:Lymphocyte Count; D008231:Lymphopenia / Q000209:etiology* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D055655:NK Cell Lectin-Like Receptor Subfamily K / Q000097:blood; D011236:Prediabetic State / Q000097:blood / Q000276:immunology*; D054341:Receptors, KIR3DL1 / Q000097:blood / Q000172:deficiency; D012306:Risk; D016176:T-Lymphocyte Subsets / Q000276:immunology
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D006683:HLA-DQ Antigens; D059866:HLA-DQ beta-Chains; C069051:HLA-DQB1 antigen; D007328:Insulin; C515083:KIR3DL1 protein, human; C527085:KLRK1 protein, human; D055655:NK Cell Lectin-Like Receptor Subfamily K; D054341:Receptors, KIR3DL1; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2
references.citation: Adv Immunol. 2008;100:1-12
references.pmid: 19111161
references.citation: Nature. 1995 Nov 16;378(6554):245-8
references.pmid: 7477341
references.citation: Diabetes. 1993 Feb;42(2):359-62
references.pmid: 8425674
references.citation: J Exp Med. 1995 Mar 1;181(3):1133-44
references.pmid: 7532677
references.citation: J Clin Immunol. 1986 Sep;6(5):363-72
references.pmid: 2429979
references.citation: Diabetes. 2007 Jan;56(1):177-85
references.pmid: 17192480
references.citation: Biotechniques. 1995 May;18(5):870-7
references.pmid: 7619493
references.citation: Adv Exp Med Biol. 1998;452:13-8
references.pmid: 9889954
references.citation: Lancet. 1977 May 14;1(8020):1025-7
references.pmid: 67485
references.citation: J Immunol Methods. 1998 Apr 1;213(1):87-97
references.pmid: 9671127
references.citation: J Clin Endocrinol Metab. 2000 Jan;85(1):76-80
references.pmid: 10634367
references.citation: Trends Mol Med. 2008 Apr;14(4):179-89
references.pmid: 18353724
references.citation: Autoimmunity. 2002 Feb;35(1):1-14
references.pmid: 11908701
references.citation: Nat Rev Immunol. 2003 Apr;3(4):304-16
references.pmid: 12669021
references.citation: Eur J Immunol. 2005 Aug;35(8):2452-8
references.pmid: 15997468
references.citation: J Immunol. 2008 Feb 1;180(3):1729-36
references.pmid: 18209070
references.citation: Immunol Today. 1997 Nov;18(11):538-42
references.pmid: 9386350
references.citation: Diabetologia. 1987 Dec;30(12):907-11
references.pmid: 3436487
references.citation: J Immunol. 2008 Apr 1;180(7):4679-86
references.pmid: 18354191
references.citation: J Exp Med. 2005 Oct 17;202(8):1075-85
references.pmid: 16230475
references.citation: Diabetologia. 1984 Jul;27 Suppl:102-5
references.pmid: 6237011
references.citation: Br Med J (Clin Res Ed). 1986 Jul 26;293(6541):244
references.pmid: 3089475
references.citation: Diabetes. 1986 Feb;35(2):237-41
references.pmid: 3510930
references.citation: Clin Chem. 1995 May;41(5):687-92
references.pmid: 7729046
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5460-5
references.pmid: 16567639
references.citation: Clin Immunol. 2004 Sep;112(3):258-67
references.pmid: 15308119
references.citation: Diabetes Care. 1995 Dec;18(12):1557-65
references.pmid: 8722051
references.citation: Cell Mol Immunol. 2006 Aug;3(4):241-54
references.pmid: 16978532
references.citation: J Immunol. 2007 Oct 1;179(7):4492-502
references.pmid: 17878345
references.citation: Diabet Med. 1994 Apr;11(3):299-303
references.pmid: 8033530
references.citation: Exp Hematol. 2007 Mar;35(3):416-25
references.pmid: 17309822
references.citation: Diabetologia. 1986 Jun;29(6):352-7
references.pmid: 3527835
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9253-7
references.pmid: 15961541
references.citation: Diabetes. 1999 Jan;48(1):150-7
references.pmid: 9892237
references.citation: Nat Rev Immunol. 2003 May;3(5):413-25
references.pmid: 12766763
references.citation: Immunity. 2003 Jan;18(1):41-51
references.pmid: 12530974
references.citation: J Clin Invest. 1993 Jan;91(1):368-74
references.pmid: 8423232
references.citation: Annu Rev Immunol. 1999;17:875-904
references.pmid: 10358776
references.citation: Eur J Immunol. 2008 Nov;38(11):2942-5
references.pmid: 18979513
references.citation: Trends Immunol. 2005 Nov;26(11):613-8
references.pmid: 16118064
references.citation: J Exp Med. 1994 Aug 1;180(2):537-43
references.pmid: 8046332
references.citation: Nat Rev Immunol. 2005 Mar;5(3):201-14
references.pmid: 15719024
references.citation: Immunol Res. 1998;17(3):303-12
references.pmid: 9638474
references.citation: J Immunol. 2001 Aug 1;167(3):1245-53
references.pmid: 11466340
references.citation: Diabetes Res Clin Pract. 1994 Feb;23(1):37-42
references.pmid: 7516851
references.citation: Immunobiology. 1990 Jun;180(4-5):431-40
references.pmid: 2204602
references.citation: Diabetologia. 1994 Apr;37(4):344-50
references.pmid: 8063033
references.citation: Nat Immunol. 2008 May;9(5):503-10
references.pmid: 18425107
references.citation: J Immunol. 2006 Feb 1;176(3):1582-7
references.pmid: 16424187
references.citation: Lancet. 1997 Nov 1;350(9087):1288-93
references.pmid: 9357409
references.citation: Diabetes Care. 1996 Aug;19(8):795-800
references.pmid: 8842593